Clearance? Approval? What Should Investors Make of Nano-X's FDA Decision?

·3-min read

Last month, Nano-X Imaging (NASDAQ: NNOX) gained 501(k) clearance from the Food and Drug Administration (FDA) for its X-ray device. In this video from Motley Fool Live, recorded on April 5, contributors Brian Orelli and Keith Speights discuss the difference between an FDA clearance and approval and what the results could mean for the medical-device maker. Brian Orelli: We have a couple of questions on Nano-X Imaging.